https://www.selleckchem.com/products/yoda1.html
d to be independent predictors for cumulative 5-year risk of (re)bleeding.Informed consent is a key concept to ensure patient autonomy in clinical trials and routine care. The coronavirus disease 2019 (COVID-19) pandemic has complicated informed consent processes, due to physical distancing precautions and increased physician workload. As such, obtaining timely and adequate patient consent has become a bottleneck for many clinical trials. However, this challenging situation might also present an opportunity to rethink and reappraise our a
Like
Comment
Share
